1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon: International Agency for Research on Cancer Press; 2007.
2. Miller DC. Surgical pathology of intramedullary spinal cord neoplasms. J Neurooncol 2000 47:189–94.
4. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006 7:392–401.
5. Arai T, Tani S, Isoshima A, et al. Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note. No Shinkei Geka 2006 34:811–7.
6. Kajimoto Y, Kuroiwa T, Miyatake S, et al. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence: case report. J Neurosurg 2007 106:1070–4.
7. Shimizu S, Utsuki S, Sato K, Oka H, Fujii K, Mii K. Photodynamic diagnosis in surgery for spinal ependymoma: case illustration. J Neurosurg Spine 2006 5:380.
8. Utsuki S, Miyoshi N, Oka H, et al. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 2007 24:53–5.
9. Bernal-Garcia LM, Cabezudo-Artero JM, Ortega-Martinez M, et al. Fluorescence-guided resection with 5-aminolevulinic acid of an intramedullary tumor. Neurocirugia (Astur) 2010 21:312–6.
11. Utsuki S, Oka H, Sato K, Shimizu S, Suzuki S, Fujii K. Fluorescence diagnosis of tumor cells in hemangioblastoma cysts with 5-aminolevulinic acid. J Neurosurg 2010 112:130–2.
12. Millesi M, Kiesel B, Woehrer A, et al. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors. Neurosurg Focus 2014 36:E11.
15. Aghakhani N, David P, Parker F, Lacroix C, Benoudiba F, Tadie M. Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit. Neurosurgery 2008 62:1279–85.
16. Chang UK, Choe WJ, Chung SK, Chung CK, Kim HJ. Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neurooncol 2002 57:133–9.
17. Lin YH, Huang CI, Wong TT, et al. Treatment of spinal cord ependymomas by surgery with or without postoperative radiotherapy. J Neurooncol 2005 71:205–10.
19. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 2000 93(2 Suppl): 183–93.
21. Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery 2005 56:972–81.
22. Nagasawa DT, Smith ZA, Cremer N, Fong C, Lu DC, Yang I. Complications associated with the treatment for spinal ependymomas. Neurosurg Focus 2011 31:E13.
24. Klekamp J. Spinal ependymomas: part 1: intramedullary ependymomas. Neurosurg Focus 2015 39:E6.
26. Ohata K, Takami T, Gotou T, et al. Surgical outcome of intramedullary spinal cord ependymoma. Acta Neurochir (Wien) 1999 141:341–6.
27. Lee J, Parsa AT, Ames CP, McCormick PC. Clinical management of intramedullary spinal ependymomas in adults. Neurosurg Clin N Am 2006 17:21–7.
28. Della Puppa A, Rustemi O, Gioffre G, et al. Predictive value of intraoperative 5-aminolevulinic acidinduced fluorescence for detecting bone invasion in meningioma surgery. J Neurosurg 2014 120:840–5.
29. Ebner FH, Roser F, Falk M, Hermann S, Honegger J, Tatagiba M. Management of intramedullary spinal cord lesions: interdependence of the longitudinal extension of the lesion and the functional outcome. Eur Spine J 2010 19:665–9.
30. Li TY, Chu JS, Xu YL, et al. Surgical strategies and outcomes of spinal ependymomas of different lengths: analysis of 210 patients: clinical article. J Neurosurg Spine 2014 21:249–59.